1. Home
  2. ADEA vs AVDL Comparison

ADEA vs AVDL Comparison

Compare ADEA & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADEA
  • AVDL
  • Stock Information
  • Founded
  • ADEA 1990
  • AVDL 2015
  • Country
  • ADEA United States
  • AVDL Ireland
  • Employees
  • ADEA N/A
  • AVDL N/A
  • Industry
  • ADEA Computer Software: Prepackaged Software
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADEA Technology
  • AVDL Health Care
  • Exchange
  • ADEA Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • ADEA 1.8B
  • AVDL 1.5B
  • IPO Year
  • ADEA N/A
  • AVDL 1996
  • Fundamental
  • Price
  • ADEA $17.29
  • AVDL $15.01
  • Analyst Decision
  • ADEA Strong Buy
  • AVDL Strong Buy
  • Analyst Count
  • ADEA 4
  • AVDL 8
  • Target Price
  • ADEA $19.50
  • AVDL $20.88
  • AVG Volume (30 Days)
  • ADEA 554.0K
  • AVDL 1.4M
  • Earning Date
  • ADEA 11-06-2025
  • AVDL 11-11-2025
  • Dividend Yield
  • ADEA 1.16%
  • AVDL N/A
  • EPS Growth
  • ADEA 80.44
  • AVDL N/A
  • EPS
  • ADEA 0.74
  • AVDL N/A
  • Revenue
  • ADEA $378,674,000.00
  • AVDL $221,075,000.00
  • Revenue This Year
  • ADEA $9.49
  • AVDL $64.56
  • Revenue Next Year
  • ADEA $4.94
  • AVDL $30.60
  • P/E Ratio
  • ADEA $23.37
  • AVDL N/A
  • Revenue Growth
  • ADEA 5.47
  • AVDL 132.35
  • 52 Week Low
  • ADEA $10.59
  • AVDL $6.38
  • 52 Week High
  • ADEA $17.84
  • AVDL $16.66
  • Technical
  • Relative Strength Index (RSI)
  • ADEA 72.43
  • AVDL 49.58
  • Support Level
  • ADEA $16.36
  • AVDL $14.85
  • Resistance Level
  • ADEA $16.98
  • AVDL $15.66
  • Average True Range (ATR)
  • ADEA 0.51
  • AVDL 0.46
  • MACD
  • ADEA 0.04
  • AVDL -0.21
  • Stochastic Oscillator
  • ADEA 79.17
  • AVDL 10.53

About ADEA Adeia Inc.

Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: